乳腺MRI背景实质强化与乳腺癌的关联:系统综述与荟萃分析
该系统综述与荟萃分析纳入18项观察性研究(1910例乳腺癌患者、2541例对照),评估乳腺动态增强MRI定性及定量背景实质强化(BPE)与乳腺癌的关联。高危人群中至少中度BPE(OR 1.6)或至少轻度BPE(OR 2.1)与乳腺癌风险升高相关,乳腺癌患者平均BPE百分比较对照高(SMD 0.5);平均风险人群中未见关联。
要点
- 高危女性中至少轻度BPE与乳腺癌风险升高相关(OR 2.1,95%CI 1.5–3.0)。
- 高危女性中至少中度BPE与乳腺癌风险升高相关(OR 1.6,95%CI 1.0–2.6)。
- 平均风险人群中BPE水平与乳腺癌无统计学显著关联。
核心结论
- 乳腺MRI测得的较高水平背景实质强化在高危女性中与乳腺癌的存在相关,但在平均风险女性中不相关。
研究设计与样本
- 研究类型为回顾性荟萃分析,纳入截至2018年7月发表的比较乳腺癌女性与无乳腺癌女性BPE定性或定量评估的观察性研究。
- 共纳入18项研究,含1910例乳腺癌女性和2541例对照参与者。
- 采用DerSimonian-Laird随机效应模型估计合并OR或标准化均数差及95%CI,采用I²统计量衡量研究间异质性。
诊断标准与关键数值
- 高危人群中至少中度BPE与乳腺癌相关(OR 1.6,95%CI 1.0–2.6,P=.04)。
- 高危人群中至少轻度BPE与乳腺癌相关(OR 2.1,95%CI 1.5–3.0,P<.001)。
- 高危人群中乳腺癌患者平均BPE百分比高于对照(标准化均数差0.5,95%CI 0.2–0.9,P=.001)。
- 平均风险人群中至少轻度BPE(P=.15)或至少中度BPE(P=.38)与乳腺癌存在无关联。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原始文献未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BackgroundThe higher level of background parenchymal enhancement (BPE) at breast MRI has the potential for early detection and prediction of the risk of breast cancer. However, conflicting findings have been reported about the association between the level of BPE at breast MRI and the presence of breast cancer.PurposeTo evaluate the association between qualitative and quantitative BPE at dynamic contrast material-enhanced MRI and breast cancer among populations with average risk and high risk separately.Materials and MethodsA retrospective meta-analysis of observational studies comparing either qualitative or quantitative assessments of BPE in women with and women without breast cancer was performed for studies published through July 2018. Pooled odds ratios (ORs) or standardized mean differences and 95% confidence intervals (CIs) were estimated by using DerSimonian-Laird random-effects models. The heterogeneity across the studies was measured by using the statistic I 2. Sensitivity analyses were conducted to test this association according to different study characteristics. P values less than or equal to 5% were considered to indicate statistically significant results.ResultsEighteen studies comprising 1910 women with breast cancer and 2541 control participants were included in the analysis. Among women with high risk, at least moderate BPE (OR, 1.6; 95% CI: 1.0, 2.6; P = .04) or at least mild BPE (OR, 2.1; 95% CI: 1.5, 3.0; P < .001) was associated with higher odds of breast cancer. Furthermore, women with breast cancer showed a higher average BPE percentage compared with control participants with high risk (standardized mean difference, 0.5; 95% CI: 0.2, 0.9; P = .001). No association was observed between at least mild BPE level (P = .15) or at least moderate BPE level (P = .38) and the presence of breast cancer among the population with average risk.ConclusionA higher level of background parenchymal enhancement measured at breast MRI is associated with the presence of breast cancer in women with high risk, but not in women with average risk.© RSNA, 2019Online supplemental material is available for this article.See also the editorial by Mann and Pinker in this issue.
引用
- Thompson CM, Mallawaarachchi I, Dwivedi DK, et al. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis. Radiology. 2019. PMID: 31237494. doi:10.1148/radiol.2019182441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。